ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1003 • 2019 ACR/ARP Annual Meeting

    TNF Inhibitors Improves Arterial Stiffness with Cs DMARDs-resistant Active Psoriatic Arthritis: A Cohort Extended Study

    Kensuke Kume1, kanzo amano 1, toshikatsu kanazawa 1, susumu yamada 1 and kazuhiko hatta 1, 1Department of Rheumatology/Hiroshima Clinic, Hiroshima, Hiroshima, Japan

    Background/Purpose: Background/ Patients with psoriatic arthritis (PsA) have an increased cardiovascular (CV) risk. We should have strategies for primary cardiovascular prevention in PsA1). But there…
  • Abstract Number: 1004 • 2019 ACR/ARP Annual Meeting

    Genetic Ablation of γδTCR Inhibits IL-23-induced Neutrophilia and Attenuates Epidermal Hyperplasia, Synovitis, Onycholysis and Enthesitis Associated with Psoriatic Arthritis

    Cuong Nguyen1, Trevor Chan 2, Ilias Tagkopoulos 2, Matthias Eberl 3 and Iannis Adamopoulos 1, 1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Sacramento, CA, 2University of California, Davis, Department of Computer Science, California, USA, Davis, CA, 3Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute, Cardiff University, Cardiff CF14 4XN, United Kingdom, Cardiff, United Kingdom

    Background/Purpose: γδ T cells are non-conventional lymphocytes that straddle between innate and adaptive immunity. Although γδ T cells have been implicated in psoriatic arthritis, the…
  • Abstract Number: 1005 • 2019 ACR/ARP Annual Meeting

    Tendon T-cell Interactions as Drivers of Chronicity in Spondyloarthritis

    Emma Garcia-Melchor 1, Giacomo Cafaro 1, Hanna Johnsson1, Lindsay Crowe 2, Michael McLean 2, James Reilly 2, Iain McInnes 3, Moeed Akbar 2 and Neal Millar 3, 1University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, 3Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Emerging evidence supports the concept that stromal cell functions extend beyond maintenance of tissue architecture, exerting a key role in choreographing immune responses and…
  • Abstract Number: 1006 • 2019 ACR/ARP Annual Meeting

    Vaspin rs35262691 Is Associated with Atherosclerotic Disease in Axial Spondyloarthritis Patients

    Fernanda Genre1, Javier Rueda-Gotor 1, Sara Remuzgo-Martinez 1, Veronica Pulito-Cueto 1, Alfonso Corrales 1, Veronica Mijares 1, Leticia Lera-Gomez 1, Virginia Portilla 1, Rosa Expósito 2, Cristina Mata 2, Iván Ferraz-Amaro 3, Vanesa Hernández-Hernández 3, Santos Castañeda 4, Esther Vicente-Rabaneda 5, Cristina Fernández-Carballido 6, M. Paz Martínez-Vidal 7, David Castro-Corredor 8, Joaquín Anino-Fernández 8, Juan Quevedo-Abeledo 9, Carlos Rodríguez-Lozano 9, Ricardo Blanco 10, María Luz García-Vivar 11, Eva Galíndez-Agirregoikoa 11, Javier Llorca 12, Raquel López-Mejías 1 and Miguel Angel González-Gay 13, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, Santander, Spain, 2Rheumatology Division, Hospital Comarcal de Laredo, Laredo, Spain, Laredo, Spain, 3Rheumatology Division, Hospital Universitario de Canarias, Tenerife, Spain, Tenerife, Spain, 4Rheumatology Department, Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Spain, Madrid, Spain, 5Rheumatology Department, Hospital Universitario La Princesa, Madrid, Spain, 6Rheumatology Division, Hospital Universitario San Juan de Alicante, Alicante, Spain, Alicante, Spain, 7Rheumatology Division, Hospital General Universitario de Alicante, Alicante, Spain, Alicante, Spain, 8Rheumatology Division, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, Ciudad Real, Spain, 9Rheumatology Division, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain, Las Palmas de Gran Canaria, Spain, 10Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Santander, Spain, 11Rheumatology Unit, Basurto University Hospital, Bilbao, Spain, Bilbao, Spain, 12School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, Santander, Spain, 13Universidad de Cantabria and IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Spain

    Background/Purpose: Vaspin is a novel adipokine with insulin-sensitizing functions that exerts anti-inflammatory actions1,2. It has been associated with cardiovascular (CV) disease, CV risk factors and…
  • Abstract Number: 1007 • 2019 ACR/ARP Annual Meeting

    Memory ex-Th17 Cells Contribute to Synovial Inflammation in Spondyloarthritis

    SO-HEE JIN 1, Pu-Reum PARK 1, Ji Hyun KANG 1, DONG-JIN PARK 1 and TAE-JONG KIM1, 1Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea

    Background/Purpose: Spondyloarthritis (SpA) is characterized by inflammation of the synovium. An increase in the number of Th17cells in SpA has been reported. However, it is…
  • Abstract Number: 1008 • 2019 ACR/ARP Annual Meeting

    C-X-C Motif Chemokine 10 (CXCL10) as a Transcriptomic Biomarker of Psoriatic Arthritis Susceptibility

    Fatima Abji1, Anastasiya Muntyanu 2, Remy Pollock 1, Rohan Machhar 1, Justine (Yang) Ye 3, Vinod Chandran 4 and Dafna Gladman 5, 1Krembil Research Institute, University Health Network, Toronto, Canada, 2University of Toronto, University Health Network, Toronto, Canada, 3University Health Network, University of Toronto, Toronto, ON, Canada, 4University Health Network, University of Toronto, Toronto, Canada, 5Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada

    Background/Purpose: We previously identified CXCL10, NOTCH2NL, HAT1, and SETD2 as differentially expressed between psoriasis arthritis (PsA) and psoriasis patients without arthritis (PsC). This study aimed…
  • Abstract Number: 1009 • 2019 ACR/ARP Annual Meeting

    PDE4 Inhibition Could Improve Endothelial and Adipose Tissue Dysfunction Associated with Psoriatic Arthritis, Key Processes in Cardiovascular Disease

    Ivan Arias de la Rosa1, Carmen Torres-Granados 1, Maria del Carmen Abalos-Aguilera 2, Ignacio Gomez-Garcia 2, Rocio Guzman-Ruiz 3, Maria del Mar Malagon 3, Carlos Perez-Sanchez 4, Alejandra Patiño-Trives 2, Maria Luque-Tevar 2, Alejandro Ibañez-Costa 2, Alejandro Escudero 5, Eduardo Collantes-Estevez 1, Chary Lopez-Pedrera 2, Maria Dolores Lopez-Montilla 2 and Nuria Barbarroja 3, 1University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain, 2IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3University of Cordoba/IMIBIC/Reina Sofia Hospital and CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Cordoba, Spain, 4Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, Cordoba, Spain, 5IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain

    Background/Purpose: Psoriatic arthritis (PsA) is the rheumatic disease most associated with metabolic disorders, including obesity and metabolic syndrome, where inflammation is a determinant key factor,…
  • Abstract Number: 1010 • 2019 ACR/ARP Annual Meeting

    IL-17A Induces Distinct Functional Differences Between Two Novel Mesenchymal Stem Cell Populations Identified at the Human Enthesis

    Tobias Russell1, Abdulla Watad 2, Charlie Bridgewood 3, Almas Khan 4, Abhay S Rao 4, Peter Loughenbury 4, Peter Milner 4, Robert Dunsmuir 4, Thomas Baboolal 3, Elena Jones 5, Richard Cuthbert 1 and Dennis McGonagle 6, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM)University of Leeds, Leeds, England, United Kingdom, 2Department of Medicine “B”, Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Ramat-Gan, Israel, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM)University of Leeds, Leeds, United Kingdom, 4Leeds Teaching Hospitals NHS Trust, Leeds, 5University of Leeds, Leeds, England, United Kingdom, 6University of Leeds, Leeds, United Kingdom

    Background/Purpose: Ankylosing spondylitis (AS) is associated with entheseal inflammation and new bone formation. Resident populations of lymphocytes have been identified at the enthesis that on…
  • Abstract Number: 1011 • 2019 ACR/ARP Annual Meeting

    Single Cell RNA Sequencing of Patients with Psoriatic Disease

    Rohan Machhar1, Kun Liang 2, Remy Pollock 1 and Dafna Gladman 3, 1Krembil Research Institute, University Health Network, Toronto, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Krembil Research Institute, U of Toronto, Toronto, ON, Canada

    Background/Purpose: Delayed diagnosis of psoriatic arthritis (PsA) can lead to poor clinical outcomes. A large proportion of PsA patients remain undiagnosed due to a lack…
  • Abstract Number: 1012 • 2019 ACR/ARP Annual Meeting

    Apremilast Inhibits Immune Cells Support of Inflammatory Osteoclastogenesis

    Yannick Degboe 1, Flavia Sunzini 1, Iain McInnes 2 and Carl Goodyear1, 1University of Glasgow, Glasgow, United Kingdom, 2Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: PsA is associated with bone erosion and inflammation-induced bone loss. This process is mediated by osteoclasts, and modulated by inflammatory cytokines (i.e. TNF, IL-1,…
  • Abstract Number: 1013 • 2019 ACR/ARP Annual Meeting

    Effects of Anti-TNF on MiR Expression in Monocytes and CD4+ T-Lymphocytes in Spondyloarthritis

    Olivier Fogel1, Maud Fagny 2, Elodie Roche 3, Nelly Sigrist 3, Jean-François Deleuze 4, Maxime Dougados 5, Corinne Miceli-Richard 1 and Jorg Tost 3, 1Paris Descartes University, Department of Rheumatology - Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France, 2CEA-CNRGH-Institut François Jacob- Laboratoire Epigenetique et Envrironnement, Evry, Ile-de-France, France, 3CEA-CNRGH-Institut François Jacob- Laboratoire Epigenetique et Envrironnement, Evry, France, 4CEA-CNRGH-Institut François Jacob, Evry, France, 5Cochin Hospital, Paris, France

    Background/Purpose: TNFα inhibitors are an effective treatment for many inflammatory diseases. However, their mechanism of action is more complicated than just blocking the targeted cytokine.…
  • Abstract Number: 1014 • 2019 ACR/ARP Annual Meeting

    Regulatory Role of IL-23 and Its Receptor System in Spondyloarthritis and Its Therapeutic Relevance in anti-IL-17 Failure Patients

    Siba Raychaudhuri1 and Smritikana Raychaudhuri 2, 1UC Davis School of Medicine, Sacramento, CA, 2UC Davis School of Medicine, Davis, CA

    Background/Purpose: Here we hypothesized that (i) IL-23/IL-23R system more specifically the specific IL-23p19 subunit mediated signaling system regulates expansion/maintenance and functional maturation in respect to…
  • Abstract Number: 1015 • 2019 ACR/ARP Annual Meeting

    Evidence for Substantial Immune Activation in Asymptomatic ANA Positive Individuals

    Emma Van Lieshout1, Dennisse Bonilla 2, Zahi Touma 3, Arthur Bookman 4, Linda Hiraki 5, Zareen Ahmad 6, Sindhu Johnson 7, Earl D. Silverman 8 and Joan Wither 9, 1University of Toronto, Toronto, ON, Canada, 2University Health Network, University of Toronto, Toronto, ON, Canada, 3University Health Network, University of Toronto, Toronto, Canada, 4University Health Network - Toronto Western Hospital, Toronto, Canada, 5The Hospital for Sick Children, Toronto, Canada, 6Mount Sinai Hospital, Toronto, Canada, 7Toronto Scleroderma Program, Department of Medicine, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Canada, Toronto, Canada, 8Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 9University Health Network, Krembil Research Institute, Toronto, ON, Canada

    Background/Purpose: Systemic autoimmune rheumatic diseases (SARD) including Sjogren’s Disease (SjD), Systemic Sclerosis (SSc) and Systemic Lupus Erythematosus (SLE) are characterized by the production of anti-nuclear…
  • Abstract Number: 1016 • 2019 ACR/ARP Annual Meeting

    Identification of Differentially Expressed Genes and Signaling Pathways in Systemic Lupus Erythematosus by Integrated Bioinformatics Analysis

    Wei Liu1, Yuanhao Wu 1 and Wenjia Zhao 1, 1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (People's Republic)

    Background/Purpose: Systemic lupus erythematosus (SLE) is a common autoimmune disease. The occurrence and development of SLE is a result of multiple factors, but its exact…
  • Abstract Number: 1017 • 2019 ACR/ARP Annual Meeting

    The Integration of Genetic Data, Molecular Pathway Analysis and Differential Expression to Delineate the Impact of Ancestral Differences on Lupus

    Katherine Owen1, Bryce Aidukaitis 1, Adam Labonte 1, Michelle Catalina 1, Prathyusha Bachali 1, Nicholas Geraci 2, Miranda Marion 3, Hannah Ainsworth 4, kip Zimmerman 3, Timothy Howard 4, Carl Langefeld 4, Peter Lipsky 2 and Amrie Grammer 5, 1AMPEL Biosolutions and the RILITE research institute, Charlottesville, VA, 2AMPEL BioSolutions, LLC, Charlottesville, VA, 3Wake Forest School of Medicine, Winston-Salem, NC, 4Wake Forest School of Medicine, Winston-Salem, 5AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disorder with a prominent genetic component. Evidence has shown that individuals of African-Ancestry (AA) experience the…
  • « Previous Page
  • 1
  • …
  • 1005
  • 1006
  • 1007
  • 1008
  • 1009
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology